Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2960 | 2178 | 24.6 | 67% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
598 | 12035 | TOXIC EPIDERMAL NECROLYSIS//STEVENS JOHNSON SYNDROME//DRUG HYPERSENSITIVITY |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
8887 | 1139 | HAND FOOT SYNDROME//RADIATION RECALL//HAND FOOT SKIN REACTION |
19413 | 442 | EXTRAVASATION//EXTRAVASATION INJURY//ANTHRACYCLINE EXTRAVASATION |
21023 | 375 | HYPERSENSITIVITY REACTIONS//HYPERSENSITIVITY REACTION//CARBOPLATIN HYPERSENSITIVITY |
30723 | 134 | SHIITAKE DERMATITIS//FLAGELLATE DERMATITIS//FLAGELLATE ERYTHEMA |
33602 | 88 | ADENINE NUCLEOTIDE DEGRADATION//METAPYRONE//ANGARSK AFFILIATED OR MED HUMAN EC |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | HAND FOOT SYNDROME | Author keyword | 56 | 58% | 3% | 64 |
2 | RADIATION RECALL | Author keyword | 42 | 83% | 1% | 24 |
3 | EXTRAVASATION | Author keyword | 31 | 24% | 5% | 113 |
4 | HAND FOOT SKIN REACTION | Author keyword | 27 | 66% | 1% | 25 |
5 | RADIATION RECALL DERMATITIS | Author keyword | 26 | 87% | 1% | 13 |
6 | NEUTROPHILIC ECCRINE HIDRADENITIS | Author keyword | 23 | 76% | 1% | 16 |
7 | PALMAR PLANTAR ERYTHRODYSESTHESIA | Author keyword | 19 | 64% | 1% | 18 |
8 | HYPERSENSITIVITY REACTIONS | Author keyword | 16 | 31% | 2% | 43 |
9 | EXTRAVASATION INJURY | Author keyword | 13 | 71% | 0% | 10 |
10 | SERIES CLIN | Address | 12 | 75% | 0% | 9 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CARBOPLATIN HYPERSENSITIVITY | 94 | 94% | 2% | 33 |
2 | ANTHRACYCLINE EXTRAVASATION | 58 | 83% | 2% | 33 |
3 | IDIOSYNCRATIC REACTIONS | 45 | 90% | 1% | 19 |
4 | NEUTROPHILIC ECCRINE HIDRADENITIS | 40 | 70% | 2% | 33 |
5 | PALMAR PLANTAR ERYTHRODYSESTHESIA | 29 | 55% | 2% | 36 |
6 | DERMATOLOGICAL TOXICITIES | 28 | 81% | 1% | 17 |
7 | FACTOR RECEPTOR INHIBITORS | 28 | 41% | 2% | 53 |
8 | ACRAL ERYTHEMA | 22 | 66% | 1% | 21 |
9 | TOPICAL DIMETHYLSULFOXIDE | 21 | 90% | 0% | 9 |
10 | DESENSITIZATION PROTOCOL | 20 | 100% | 0% | 9 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Nail toxicities induced by systemic anticancer treatments | 2015 | 1 | 47 | 68% |
Interdisciplinary management of EGFR-inhibitor-induced skin reactions: a German expert opinion | 2011 | 36 | 41 | 78% |
Management of Hypersensitivity Reactions to Carboplatin and Paclitaxel in an Outpatient Oncology Infusion Center: A 5-Year Review | 2014 | 4 | 18 | 78% |
Indications, Protocols, and Outcomes of Drug Desensitizations for Chemotherapy and Monoclonal Antibodies in Adults and Children | 2014 | 5 | 28 | 64% |
Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities | 2011 | 58 | 79 | 35% |
Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors | 2012 | 18 | 41 | 61% |
The hand-foot-syndrome associated with medical tumor therapy - classification and management | 2010 | 31 | 42 | 74% |
Skin toxicities associated with epidermal growth factor receptor inhibitors | 2009 | 96 | 62 | 42% |
Extravasation of systemic hemato-oncological therapies | 2004 | 65 | 20 | 95% |
Hand-Foot Syndrome (Hand-Foot Skin Reaction, Palmar-Plantar Erythrodysesthesia): Focus on Sorafenib and Sunitinib | 2009 | 60 | 68 | 60% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SERIES CLIN | 12 | 75% | 0.4% | 9 |
2 | HEPATOGASTROENTEROL GASTROINTESTINAL ONCOL | 3 | 100% | 0.1% | 3 |
3 | ADVERSE DRUG REACT DESENSITIZAT PROGRAM | 2 | 67% | 0.1% | 2 |
4 | ALLERGOL ONCOL SERV | 2 | 67% | 0.1% | 2 |
5 | ARTHUR G JAMES CANC HOSPMED | 2 | 67% | 0.1% | 2 |
6 | NW MEM FDN | 2 | 67% | 0.1% | 2 |
7 | CANC SKIN CARE PROGRAM | 1 | 100% | 0.1% | 2 |
8 | HUMAN HEREDITARY PATHOL DERMATOL | 1 | 50% | 0.1% | 2 |
9 | NURSING CANC | 1 | 100% | 0.1% | 2 |
10 | POLICLIN SAN MATTEO DERMATOL | 1 | 100% | 0.1% | 2 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000016025 | TOXIC EPIDERMAL NECROLYSIS//STEVENS JOHNSON SYNDROME//DRUG HYPERSENSITIVITY |
2 | 0.0000013353 | FIBRILLARY GLOMERULONEPHRITIS//NAIL PATELLA SYNDROME//YELLOW NAIL SYNDROME |
3 | 0.0000010380 | NON SMALL CELL LUNG CANCER//XRCC1//GEFITINIB |
4 | 0.0000010298 | L ASPARAGINASE//ASPARAGINASE//ERWINIA ASPARAGINASE |
5 | 0.0000009912 | INTRAPERITONEAL CHEMOTHERAPY//CYTOREDUCTIVE SURGERY//PERITONEAL CARCINOMATOSIS |
6 | 0.0000009762 | CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY//VINFLUNINE//VINCRISTINE |
7 | 0.0000008708 | DIHYDROPYRIMIDINE DEHYDROGENASE//5 FLUOROURACIL//THYMIDINE PHOSPHORYLASE |
8 | 0.0000006872 | MICROSATELLITE INSTABILITY//LYNCH SYNDROME//HNPCC |
9 | 0.0000006792 | HER 2//TRASTUZUMAB//LAPATINIB |
10 | 0.0000005646 | CARCINOMA RENAL CELL//PARTIAL NEPHRECTOMY//NEPHRECTOMY |